| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/21/2005 | US20050084504 Methods for treating various disorders with a neurotoxic component of a botulinum toxin |
| 04/21/2005 | US20050084496 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 04/21/2005 | US20050084491 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/21/2005 | US20050084490 Boroproline compound combination therapy |
| 04/21/2005 | US20050084489 Synergistic administration of Vitaxin, a FAB fragment, or a competitive binding antibody for binding integrin alpha V beta 3 with the enzyme inhibitor; antiinflammatory, anticarcinogenic agents; autoimmune and metabolic bone disorders |
| 04/21/2005 | US20050084487 Bone disorders, antiarthritic agents; immunizing transgenic knockout animals to obtain anti-WIF-1 antibodies |
| 04/21/2005 | US20050084486 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product |
| 04/21/2005 | US20050084478 Combination therapy using interferon-tau |
| 04/21/2005 | US20050084477 Gene expression inhibition of suppressors of cytokine signalling by administering a controlled dose of a cytokine, including insulin, insulin-like growth factor, an interleukin, interferon, growth hormone, thrombopoietin, prolactin, stem cell factor, erythropoietin or tumor necrosis factor |
| 04/21/2005 | CA2578473A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | CA2550583A1 Modified cea /b7 vector |
| 04/21/2005 | CA2546730A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 04/21/2005 | CA2542608A1 Igf-i responsive gene and use thereof |
| 04/21/2005 | CA2542593A1 Filamentous haemagglutinin in the treatment and/or prophylaxis of immune-mediated disorders |
| 04/21/2005 | CA2542479A1 Sperm protective polypeptides and uses thereof |
| 04/21/2005 | CA2542179A1 Il-21 derivatives |
| 04/21/2005 | CA2542099A1 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 04/21/2005 | CA2542054A1 Use of somatostatin or one of the analogs thereof for producing a medicament serving to regulate the ovarian follicular reserve in non-menopausal women |
| 04/21/2005 | CA2542046A1 Fused protein composition |
| 04/21/2005 | CA2542035A1 Process for producing antithrombin iii composition |
| 04/21/2005 | CA2541804A1 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | CA2541607A1 Therapeutic agents for renal diseases |
| 04/21/2005 | CA2541603A1 Agent for improving mental disorders |
| 04/21/2005 | CA2541380A1 Use of cell lines to produce active therapeutic proteins |
| 04/21/2005 | CA2541360A1 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 04/21/2005 | CA2541060A1 Compositions and methods for treatment of muscle pain and muscle wasting |
| 04/21/2005 | CA2540838A1 Process for the synchronization of ovulation for timed breeding without heat detection |
| 04/21/2005 | CA2540775A1 Medical use of tbk-1 or of inhibitors thereof |
| 04/21/2005 | CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 04/21/2005 | CA2538418A1 Synthetic polysaccharide antigens for immunological intervention in disease |
| 04/21/2005 | CA2537473A1 Cytokine involved in epithelial-mesenchymal transition |
| 04/21/2005 | CA2535982A1 Uses of interferons with altered spatial structure |
| 04/21/2005 | CA2532837A1 Method for preparing small spherical particles by controlled phase separation |
| 04/20/2005 | EP1524272A1 Growth hormone secretagogues |
| 04/20/2005 | EP1523993A1 Polypeptide compositions with improved stability |
| 04/20/2005 | EP1523990A1 Cellular vesicles denoted as 'exosomes', their preparation and use in the stimulation of an immune response |
| 04/20/2005 | EP1523982A2 Plenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 04/20/2005 | EP1523582A2 Rapid, efiicient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 04/20/2005 | EP1523577A2 Method for diagnosis of intestinal-type gastric tumors |
| 04/20/2005 | EP1523571A2 Sgk and nedd used as diagnostic and therapeutic targets |
| 04/20/2005 | EP1523501A1 Inhibition of cell division based use of analogs of neuropeptide y |
| 04/20/2005 | EP1523495A2 Peptides for inducing apoptosis in tumor cells |
| 04/20/2005 | EP1523494A2 Beta-sheet forming peptides and material made thereof |
| 04/20/2005 | EP1523493A1 Novel tubulysin analogues |
| 04/20/2005 | EP1523489A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 04/20/2005 | EP1523372A2 Ghrelin-carrier conjugates |
| 04/20/2005 | EP1523336A1 Targeted agents for nerve regeneration |
| 04/20/2005 | EP1523328A2 Methods and compositions for inhibiting hiv replication |
| 04/20/2005 | EP1523327A1 Pharmaceutical active ingredient preparations and medicaments that contain thrombin or have a thrombin-generating capacity |
| 04/20/2005 | EP1523326A2 Insulin-associated peptides with effects on cerebral health |
| 04/20/2005 | EP1523325A2 Methods and compositions for treating polycystic ovary syndrome |
| 04/20/2005 | EP1523324A1 Treatment of serious infections and septic shock |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1523322A2 Novel proteins and nucleic acids encoding same |
| 04/20/2005 | EP1523243A1 Milk protein isolate and method for preparing same |
| 04/20/2005 | EP1401456A4 Method fron determining the efficacy of reverse cholesterol transport enhancing agents |
| 04/20/2005 | EP1355920A4 Extractive purification of lipopeptide antibiotics |
| 04/20/2005 | EP1318829B1 Angiogenic tri- or tetrapeptides derived from AcSDKP |
| 04/20/2005 | EP1254161B1 Aerothricin analogs, their preparation and use |
| 04/20/2005 | EP1196184B1 Compositions for treatment of sexual dysfunction |
| 04/20/2005 | EP1189926B1 Rapid dehydration of proteins |
| 04/20/2005 | EP1175435B1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof |
| 04/20/2005 | EP1141326B1 Human akt-3 |
| 04/20/2005 | EP1079853B1 Tuber or root derived protease inhibitors for preventing or treating inflammation or pruritis |
| 04/20/2005 | EP1049481B1 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 04/20/2005 | EP1047452B1 Conjugates comprising two active agents |
| 04/20/2005 | EP1041890B1 Carbohydrate oxidase and use thereof in baking |
| 04/20/2005 | EP1009753B1 Hypoxia-regulated genes |
| 04/20/2005 | EP0989994B1 Streptogramines, their preparation and compositions containing them |
| 04/20/2005 | EP0956303B1 Non-naturally occurring lipoprotein particle |
| 04/20/2005 | EP0835301B1 Monoclonal antibody directed against rat beta 2 integrin alpha d subunit and corresponding hybridoma |
| 04/20/2005 | EP0831886B1 Thrombopoietin compositions |
| 04/20/2005 | EP0805859B1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses |
| 04/20/2005 | EP0775213B1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 04/20/2005 | EP0759995B1 Fusion glycoprotein from hcmv and hsv |
| 04/20/2005 | EP0700430B1 Methods for selectively stimulating proliferation of t cells |
| 04/20/2005 | CN1608131A Drug for adenocarcinoma of pancreas |
| 04/20/2005 | CN1608079A Chemically-modified human growth hormone conjugates |
| 04/20/2005 | CN1608078A Gonadotrophins for folliculogenesis |
| 04/20/2005 | CN1608062A Salt forms of e-2-methoxy-n-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607958A Liquid composition of modified factor vii polypeptides |
| 04/20/2005 | CN1607957A Modulation of excitable tissue function by peripherally administered erythropoietin |
| 04/20/2005 | CN1607949A Peptide arginals and methods for treating disseminated intravascular coagulation |
| 04/20/2005 | CN1607942A Pharmaceutical compositions in particulate form |
| 04/20/2005 | CN1607941A Pharmaceutical compositions in particulate form |
| 04/20/2005 | CN1607391A Method for predicating time of taking out ova for external fertilization |
| 04/20/2005 | CN1607248A Multifunctional anticancer recombinant adenovirus |
| 04/20/2005 | CN1607209A Poly thymosin-alpha 1, its composition, its preparation method and application |
| 04/20/2005 | CN1607006A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/20/2005 | CN1607003A Auxiliary therapeutic agent for C type hepatitis |
| 04/20/2005 | CN1197968C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 04/20/2005 | CN1197966C Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 04/20/2005 | CN1197956C Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 04/20/2005 | CN1197874C Modification and preparation of human interleukin 11 |
| 04/20/2005 | CN1197617C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 04/20/2005 | CN1197616C Oral peptide pharmaceutical products |
| 04/19/2005 | US6881833 Component in the hedgehog signalling pathway |